Increased Success Rate for Chemotherapy in Breast Cancer

category: Dafé’s Café - Daily Dose of Medical News,MyDocHub
by Dafé,

Researchers from the University of Bordeaux, France, reported that the success rate of chemotherapy in breast cancer can be increased by targeting patients with the most sensitive tumors, using a new test involving genomic signatures. According to the researchers, “selection of the treatment regimen with our genomic signatures has the potential to increase the pathological response rate from 44 percent to around 70 percent.”

The findings which was reported in The Lancet Oncology, and led by Professor Herve Bonnefoi, offers more hope to many breast cancer patients. Professor Herve Bonnefoi, said: “Treatment for breast cancer has become more efficient in the past decade but the downside is that treatments have become more aggressive and have to be taken for longer. It is to avoid this that we are doing this research. We are trying to identify groups of patients who need lighter chemotherapy or shorter treatment. We are trying to develop tailor-made treatment and this study is a good signal that we are going in the right direction.”

Comments

1 Comment so far

Increased Success Rate for Chemotherapy in Breast Cancer by cancer.MEDtrials.info | 16 November 2007, 18:32
[...] most sensitive tumors, using a new test involving genomic signatures. …article continues at DafÃ© brought to you by cancer.medtrials.info and [...]